Death, autoantigen modifications, and tolerance
- PMID: 11094420
- PMCID: PMC129993
- DOI: 10.1186/ar75
Death, autoantigen modifications, and tolerance
Abstract
Autoantibodies present in the serum of patients with a variety of inflammatory diseases have proven useful as diagnostic markers and as probes with which to elucidate biochemical and signaling pathways. The mechanisms governing the generation of autoantibodies remain elusive, constituting a critical missing link in our understanding of rheumatologic illnesses. Several lines of experimentation in recent years have strongly implicated events surrounding cell death in this process. This review will address the potential role played by death-specific modifications of autoantigens in bypassing tolerance to highly conserved autoantigens, including nucleic acids, lipids, and proteins.
Comment in
-
Citrullination: a small change for a protein with great consequences for rheumatoid arthritis.Arthritis Res. 2000;2(4):249-51. doi: 10.1186/ar95. Epub 2000 May 24. Arthritis Res. 2000. PMID: 11094435 Free PMC article. Review.
References
-
- Utz PJ, Anderson P. Posttranslational modifications, apoptosis, and bypass of tolerance to autoantigens. Arthritis Rheum. 1998;41:1152–1160. - PubMed
-
- Casciola-Rosen LA, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus. 1997;6:175–180. - PubMed
-
- Levine J, Koh J. The role of apoptosis in autoimmunity:immunogen, antigen, and accelerant. Semin Nephrol. 1999;19:34–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
